Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden
暂无分享,去创建一个
P. Andersen | V. Meininger | F. Salachas | J. Bouchard | G. Rouleau | G. Rouleau | M. D'Amour | W. Camu | P. Dion | P. Hince | N. Dupré | P. Valdmanis | E. Kabashi | P. Andersen | A. Dyck | J. Lee | F. Souchon | M. D'amour | Guy A. Rouleau | J. Bouchard | Nicolas Dupré | Peter M. Andersen
[1] R. Ophoff,et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.
[2] Kuixing Zhang,et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.
[3] S. Cronin,et al. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[4] R. Trent,et al. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. , 2007, Neurotoxicology.
[5] Sonja W. Scholz,et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.
[6] M. Małecki,et al. Paraoxonase gene polymorphisms and sporadic ALS , 2006, Neurology.
[7] J. Haines,et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS , 2006, Neurology.
[8] S. Ennis,et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.
[9] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[10] C. Armon. Excess incidence of ALS in young Gulf War veterans , 2004, Neurology.
[11] M. Thun,et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.
[12] E. Trabetti,et al. Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction , 2004, European journal of clinical investigation.
[13] S. Grambow,et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations , 2003, Neurology.
[14] F. Dudbridge. Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.
[15] Y. Stern,et al. Premorbid weight, body mass, and varsity athletics in ALS , 2002, Neurology.
[16] S. Reddy,et al. Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.
[17] W. Longstreth,et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. , 2000, American journal of epidemiology.
[18] J. Shefner,et al. Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis , 1999, Neuroepidemiology.
[19] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[20] P. Andersen,et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase , 1995, Nature Genetics.
[21] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[22] J. Slattery,et al. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[23] S. Adkins,et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.
[24] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[25] P. Durrington,et al. Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein , 1991, FEBS letters.
[26] W G Alvord,et al. Familial Amyotrophic Lateral Sclerosis, 1850-1989: A Statistical Analysis of the World Literature , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[27] Till Acker,et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.
[28] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.